Global Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

  • Report ID: BMRC 49 | Number of pages: 200 | Publish Date: Dec 2019
    Status: Published | Category: Pharmaceutical | Delivery Timeline: 48 hrs


COVID-19
To know the impact of COVID-19 On Global Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025 Market

Request Now

Market Size Graph


Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Rising occurrence of pancreatic cancer, the convenience of a less drug therapeutic selections for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the early phases of pancreatic cancer are some key drivers for Global Sunitinib Malate Market.

Scope of Global Sunitinib Malate Market Reports –

 Sunitinib Malate is the small molecule, orally bioavailable malate salt of an indolinone-based multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the Food and Drug Administration (FDA) for the treatment of Carcinoma. Sunitinib Malate is having molecular formula C22H27FN4O2 so molecular weight is 398.482 g/mol. The possible antineoplastic activity of Sunitinib has managed to it being observed as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treatment of Pancreatic Neuroendocrine Tumors, Kidney Cancer and Gastrointestinal Stromal Tumor (GIST).

Mechanism of action of Sunitinib Malate is it prevents cellular signaling by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib Malate also inhibits CD117 (c-KIT), the receptor tyrosine kinase that drives the many gastrointestinal stromal cell tumors. The side effects of Sunitinib Malate are Diarrhea, Heartburn, Hypertension, fatigue, Nausea and Vomiting, skin discoloration, cough, upset stomach, hair loss, fever, abdominal pain, shortness of breath, watery eyes, numbness or tingling of the arms or legs and swelling around the eyes.

Global Sunitinib Malate Market has been segmented on the basis of Application and Geography. On the basis of Application Global Sunitinib Malate Market is classified into Pancreatic Neuroendocrine Tumors, Advanced Kidney Cancer, Gastrointestinal stromal tumor (GIST) and others.

The regions covered in Global Sunitinib Malate Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Sunitinib Malate Market Key Players –

  • Pfizer
  • Topcare pharmaceutical Co. Ltd
  • Nanjing First Pharmaceutical Co. Ltd.
  • J&K Scientific
  • Target Molecule Corp.
  • Medichem
  • Biotechnica Pharma Global
  • Beijing Lunarsun Pharmaceutical Co. LTD
  • Brawn Laboratories Ltd INDIA
  • Hetero Drugs Ltd INDIA
  • Hikma Pharmaceutical plc
  • Jeil Pharmaceutical Co. Ltd
  • Natco Pharma LTD
  • Reliance Life Sciences Pvt. Ltd
  • Shilpa Medicare Ltd INDIA
  • Sichuan Xieli Pharmaceutical Co LTD
  • Synthland Ltd and Teva Pharmaceutical Industries Ltd.

Market Dynamics –

Rising incidence of pancreatic neuroendocrine tumors, pancreatic cancer is a main driver for the Global Sunitinib Malate Market. Likewise, accessibility of an inadequate number of drug therapeutics for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the initial phases of pancreatic cancer is increasing the demand of Sunitinib Malate in the treatment of pancreatic cancer. Conversely high cost of Sutent is one of the key restraints of the Global Sunitinib Malate Market growth. For 28 capsules of Sutent 37.5mg average cash price is $17,968.99. Some side effects of Sutent such as Hepatotoxicity and Adverse cardiovascular events like heart failure, myocardial infarction and coronary artery bypass grafting have also been reported during clinical trials, which could discourage adoption of the drug. Increase in awareness about the disease and technological expansions are likely to raise the Global Sunitinib Malate Market. Also Rising Prevalence of Cancer, Increase in Pharmaceutical R&D Spending, Rising Healthcare Expenditure and Rising Asian Population will boost the Global Sunitinib Malate Market. Systematic Drugs under Pipeline, Rising Scope for Cancer Therapy and increasing awareness towards Carcinoma are some opportunities in the forecast period for the Global Sunitinib Malate Market.

Regional Analysis –

North America holds the largest share of Global Sunitinib Malate Market amongst others. It is mainly driven by quickly increasing incidence of pancreatic cancer.  Moreover the incomes of customers and health insurance cover for life-threatening diseases in U.S. are very high which raises the affordability of cancer treatment. In recent years, US Food and Drug Administration (USFDA) has taken initiatives to support the progress of cancer drugs market by providing pre-market approval to the drugs, which are in the clinical phase therefore hastening the clinical development. Asia-Pacific is likely to grow vastly in the future due to some factors such as high occurrence of cancer, rising awareness regarding cure and treatment of cancer and increasing partnership between public and private areas to offer innovative cancer therapy in the region. The incidence of various types of cancer is much more in developing countries which concentrate these regions as favorable locations to conduct clinical trials. Furthermore the cost of clinical research is less in these regions due to the accessibility of a vast population base and favorable government policies contributing to the cancer drugs market growth in the developing countries.

Key Benefits for Market Reports –

  • Global Sunitinib Malate Market report covers in depth historical and forecast analysis.
  • Global Sunitinib Malate Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Sunitinib Malate Market report helps to identify opportunities in market place.
  • Global Sunitinib Malate Market report covers extensive analysis of emerging trends and competitive landscape.

Sunitinib Malate Market Segmentation –

By Application Analysis - Pancreatic Neuroendocrine Tumors, Advanced Kidney Cancer, Gastrointestinal stromal tumor (GIST), Other

By Regional & Country Analysis

North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa


Frequently Asked Questions (FAQ) :
North America holds the largest share of Global Sunitinib Malate Market amongst others. It is mainly driven by quickly increasing incidence of pancreatic cancer. Moreover the incomes of customers and health insurance cover for life-threatening diseases in U.S. are very high which raises the affordability of cancer treatment.
Global Sunitinib Malate Market report covers in depth historical and forecast analysis, Global Sunitinib Malate Market report helps to identify opportunities in market place, Global Sunitinib Malate Market report covers extensive analysis of emerging trends and competitive landscape.
Sunitinib Malate Market reports cover prominent players like Pfizer, Topcare pharmaceutical Co. Ltd, Nanjing First Pharmaceutical Co. Ltd., J&K Scientific, Target Molecule Corp., Medichem, Biotechnica Pharma Global, Beijing Lunarsun Pharmaceutical Co. LTD, Brawn Laboratories Ltd INDIA, Hetero Drugs Ltd INDIA, Hikma Pharmaceutical plc, Jeil Pharmaceutical Co. Ltd, Natco Pharma LTD, Reliance Life Sciences Pvt. Ltd, Shilpa Medicare Ltd INDIA, Sichuan Xieli Pharmaceutical Co LTD, Synthland Ltd and Teva Pharmaceutical Industries Ltd.



Interested in this report?

Global Sunitinib Malate Market Overview to 2020 - 2025 and Analysis 2019-2025


Table of Content

  1. Chapter – Report Methodology
    Research Process
    Primary Research
    Secondary Research
    Market Size Estimates
    Data Triangulation
    Forecast Model
    USP’s of Report
    Report Description
  2. Chapter – Global Sunitinib Malate Market Overview: Qualitative Analysis
    Market Introduction
    Executive Summary
    Global Sunitinib Malate Market Classification
    Market Drivers
    Market Restraints
    Market Opportunity
    Global Sunitinib Malate Market: Trends
    Porter’s Five Forces Analysis
    Bargaining Power of Suppliers
    Bargaining Power of Consumers
    Threat of New Entrants
    Threat of Substitute Product and Services
    Competitive Rivalry within the Industry
    Market Attractiveness Analysis
    Market Attractiveness Analysis by Segmentation
    Market Attractiveness Analysis by Region
  3. Chapter – Global Sunitinib Malate Market Overview: Quantitative Analysis
    Global Sunitinib Malate Market Production (Kg), Market Share (%) and Growth Rate (%), 2014- 2024
    Global Sunitinib Malate Market Consumption (Kg), Market Share ( %) and Growth Rate, 2014- 2024
    Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  4. Chapter – Global Sunitinib Malate Market : by Application
  5. Chapter – Global Sunitinib Malate Market : by Manufacturer
    Global Sunitinib Malate Market (USD Million), by Manufacturer, 2014 – 2024
    Global Sunitinib Malate Market Production (Kg), by Manufacturer, 2014 – 2024
    Global Sunitinib Malate Market Consumption (Kg), Manufacturer, 2014 – 2024
    Global Sunitinib Malate Market Share (%), by Manufacturer, 2017
    Global Sunitinib Malate Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    Global Sunitinib Malate Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    Merger & Acquisition
    Collaborations and Partnership
    New Product Launch
  6. Chapter – Global Sunitinib Malate Market: Regional Analysis
    North America
    North America Global Sunitinib Malate Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    North America Global Sunitinib Malate Market Revenue (USD Million) By Country, 2014 – 2024.
    North America Global Sunitinib Malate Market Revenue Market Share (%) By Country, 2014 – 2024.
    North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    Europe
    Asia Pacific
    Latin America
    Middle East & Africa
  7. Chapter – Company Profiles
    Pfizer
    Overview
    Financials
    Product portfolio
    Global Sunitinib Malate Market Revenue (USD Million), Production     (Kg), Consumption (Kg) and Market Share (%), 2014 – 2017
    Global Sunitinib Malate Market Share (%), 2014 – 2017
    Business strategy
    Recent developments
    Topcare pharmaceutical Co. Ltd
    Nanjing First Pharmaceutical Co. Ltd.
    J&K Scientific
    Target Molecule Corp.
    Medichem
    Biotechnica Pharma Global
    Beijing Lunarsun Pharmaceutical Co. LTD
    Brawn Laboratories Ltd INDIA
    Hetero Drugs Ltd INDIA
    Hikma Pharmaceutical plc
    Jeil Pharmaceutical Co. Ltd
    Natco Pharma LTD
    Reliance Life Sciences Pvt. Ltd
    Shilpa Medicare Ltd INDIA
    Sichuan Xieli Pharmaceutical Co LTD
    Synthland Ltd
    Teva Pharmaceutical Industries Ltd.
    Others

 

Global Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

  • Full Name * :
  • Bussiness Email * :
  • Job Title :
  • Company :
  • Contact No * :
  • Country * :
  • Any Query * :
  • Captcha * :
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Choose License Type ( Price )

Single user license, allowing one specific user access to the product.
Multi-users license, allowing up to five users access to the product.
Corporte license . Allows all employees within your organization to access product.


American Express Citi Bank Credit/Debit Card Maestro Payment Master Card PayPal Visa Wire Transfer

+44-1173181773
alan@brandessenceresearch.biz

Looking for Regional Reports?